Basilea Bonds tendered in an aggregate principal amount of approximately CHF 47 million

    NEXT STORY
    Orion Corporation’s financial reporting and Annual General Meeting in 2021
    PREV STORY
    ALX Oncology Announces Pricing of Initial Public Offering
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Apabetalone’s Positive Effect on Hospitalized Patients Involving Heart Failure

    author_avatar
    NASDAQ Market News

    Cue Biopharma Announces Publication in The Journal of Clinical Investigation Highlighting Immuno-STAT Biologics for the Treatment of Chronic Infectious Diseases

    author_avatar
    NASDAQ Market News

    Telix Pharmaceuticals Submits New Drug Application to US FDA for Prostate Cancer Imaging Product

    author_avatar
    NASDAQ Market News